American Factory TrackerMethodology
Industry IntelligenceAll Industries

Pharmaceuticals

Post-pandemic supply-chain pressure and bipartisan concern about US reliance on overseas active-pharmaceutical-ingredient (API) production drove an unprecedented wave of domestic pharmaceutical capacity announcements beginning in 2023. Eli Lilly, Novo Nordisk, and Johnson & Johnson lead capacity commitments that exceed any peer's investment in the prior two decades, much of it tied to GLP-1, oncology, and biologics demand.

Projects
12
Investment
$37.90B
Jobs
7,465
Companies
8
States
9
Geographic Distribution

Projects across the country

Largest announced project
Pharmaceuticals

Eli Lilly

Lebanon, Indiana
Investment
$9.00B
Open project →
Largest employer by jobs
Pharmaceuticals

Novartis

East Hanover, New Jersey
Expected jobs
1,000
Open project →
Top investing states

Pharmaceuticals by state

  1. Indiana
    1 projects
    900 jobs
    $9.00B
  2. North Carolina
    3 projects
    2,100 jobs
    $7.10B
  3. Texas
    1 projects
    615 jobs
    $6.50B
  4. Alabama
    1 projects
    450 jobs
    $6.00B
  5. Virginia
    1 projects
    650 jobs
    $5.00B
  6. California
    2 projects
    750 jobs
    $1.45B
  7. New Jersey
    1 projects
    1,000 jobs
    $1.10B
  8. Delaware
    1 projects
    500 jobs
    $1.00B
  9. Massachusetts
    1 projects
    500 jobs
    $750.0M
Top companies

By announced investment

  1. Eli Lilly
    5 projects
    3,215 jobs
    $27.50B
  2. Novo Nordisk
    1 projects
    1,000 jobs
    $4.10B
  3. Johnson & Johnson
    1 projects
    500 jobs
    $2.00B
  4. Novartis
    1 projects
    1,000 jobs
    $1.10B
  5. Merck
    1 projects
    500 jobs
    $1.00B
  6. Gilead Sciences
    1 projects
    450 jobs
    $847.0M
  7. Moderna
    1 projects
    500 jobs
    $750.0M
  8. Amgen
    1 projects
    300 jobs
    $600.0M
Timeline

Announcement chronology

  1. Oct 22, 2025Eli LillyGoochland County, Virginia · Pharmaceuticals$5.00B
  2. May 7, 2025Eli LillyHuntsville, Alabama · Pharmaceuticals$6.00B
  3. Apr 10, 2025NovartisEast Hanover, New Jersey · Pharmaceuticals$1.10B
  4. Mar 21, 2025Johnson & JohnsonWilson, North Carolina · Pharmaceuticals$2.00B
  5. Feb 26, 2025Eli LillyHouston, Texas · Pharmaceuticals$6.50B
  6. Sep 12, 2024Amgen (Science Innovation Center)Thousand Oaks, California · Pharmaceuticals$600.0M
  7. Jun 24, 2024Novo NordiskClayton, North Carolina · Pharmaceuticals$4.10B
  8. Apr 25, 2024Gilead SciencesFoster City, California · Pharmaceuticals$847.0M
  9. Apr 9, 2024MerckWilmington, Delaware · Pharmaceuticals$1.00B
  10. Apr 26, 2023Eli LillyLebanon, Indiana · Pharmaceuticals$9.00B
  11. Dec 19, 2022ModernaMarlborough, Massachusetts · Pharmaceuticals$750.0M
  12. Mar 29, 2022Eli LillyConcord, North Carolina · Pharmaceuticals$1.00B
Every tracked project

Pharmaceuticals ledger · 12

CompanyIndustryLocationStatusInvestmentJobsAnnounced
Eli LillyPharmaceuticalsGoochland County, VirginiaPlanning$5.00B650Oct 22, 2025
Eli LillyPharmaceuticalsHuntsville, AlabamaPlanning$6.00B450May 7, 2025
NovartisPharmaceuticalsEast Hanover, New JerseyPlanning$1.10B1,000Apr 10, 2025
Johnson & JohnsonPharmaceuticalsWilson, North CarolinaUnder Construction$2.00B500Mar 21, 2025
Eli LillyPharmaceuticalsHouston, TexasPlanning$6.50B615Feb 26, 2025
Amgen (Science Innovation Center)PharmaceuticalsThousand Oaks, CaliforniaUnder Construction$600.0M300Sep 12, 2024
Novo NordiskPharmaceuticalsClayton, North CarolinaUnder Construction$4.10B1,000Jun 24, 2024
Gilead SciencesPharmaceuticalsFoster City, CaliforniaUnder Construction$847.0M450Apr 25, 2024
MerckPharmaceuticalsWilmington, DelawareUnder Construction$1.00B500Apr 9, 2024
Eli LillyPharmaceuticalsLebanon, IndianaUnder Construction$9.00B900Apr 26, 2023
ModernaPharmaceuticalsMarlborough, MassachusettsUnder Construction$750.0M500Dec 19, 2022
Eli LillyPharmaceuticalsConcord, North CarolinaOperational$1.00B600Mar 29, 2022
Back to the tracker

Made with Emergent